House Energy and Commerce Committee subpanel chairs
Democratic Caucus of the House Energy and Commerce Committee announces subcommittee assignments for the 111 Congress, following the takeover of the chairmanship of the full committee by Rep. Henry Waxman, D-Calif., from Rep. John Dingell, D-Mich., in November ("1The Gray Sheet" Nov. 24, 2008, p. 5). Rep. Frank Pallone, D-N.J., will retain his chairmanship of the Health Subcommittee, which handles most FDA-related legislation, and Bart Stupak, D-Mich., who has been trying to persuade the incoming Obama administration to "clean house" at FDA, will retain his chairmanship of the Oversight and Investigations subpanel. Stupak sent a letter in December to the Obama transition team, asking, among other things, that no current senior FDA employee be put in charge of the agency, even on an interim basis ("2The Gray Sheet" Dec. 15, 2008, p. 23)
More from Archive
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
More from Medtech Insight
BioWales in London 2025 showcased the efforts healthtech innovators are making to meet investors on their own turf, illustrating changing attitudes and evolving needs.
Ahead of the 11 June UK spending review and its anticipated funding uplift for healthcare and life sciences, the MHRA announced an expansion of its digital expertise by creating a dedicated hub in Leeds, a renowned center of medtech excellence.
The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.